Rashin nauyi Semaglutide CAS 910463-68-2
Bayani
Semaglutide(910463-68-2) magani ne na rigakafin ciwon sukari wanda ake siyarwa a ƙarƙashin sunaye kamar Ozempic, Wegovy, da Rybelsus.Ana amfani da shi don kula da nau'in ciwon sukari na 2 da sarrafa nauyin nauyi.Magungunan yana aiki kama da glucagon-kamar peptide-1 (GLP-1) ta hanyar haɓaka ƙwayar insulin, wanda ke haifar da ingantaccen metabolism na sukari.Ana rarraba shi azaman allurar subcutaneous mai mitoci a cikin alkalami da aka riga aka cika, ko azaman nau'in baka.Ɗaya daga cikin fa'idodinsa akan sauran magungunan rigakafin ciwon sukari shine yana da tsayin daka na aiki, don haka, allura sau ɗaya kawai a mako ya wadatar.
Amfani
Ana amfani da Semaglutide don sarrafa nau'in ciwon sukari na 2 tare da canje-canjen salon rayuwa, kamar ƙuntatawa na abinci da ƙara yawan motsa jiki.Hakanan yana aiki ta hanyar rage motsin abinci ta cikin ciki kuma yana iya rage sha'awar ci da haifar da asarar nauyi.Babu wani rahoto da aka buga na hepatotoxicity wanda aka danganta ga maganin semaglutide.
Hanyar aiki
Semaglutide shine agonist mai karɓa na glucagon-kamar peptide-1.Yana ƙara samar da insulin, hormone wanda ke rage yawan sukarin jini.Hakanan yana bayyana yana haɓaka haɓakar ƙwayoyin β a cikin pancreas, waɗanda sune wuraren samar da insulin.Hakanan yana hana glucagon, wanda shine hormone wanda ke ƙara yawan sukari a cikin jini.Har ila yau yana rage cin abinci ta hanyar rage sha'awar abinci kuma yana jinkirta narkewa a cikin ciki.Ta haka yana rage kitsen jiki.
Ayyukan Halittu
Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), wani dogon aiki glucagon-kamar peptide 1 (GLP-1) analogue, shine GLP-1 agonist mai karɓa tare da yuwuwar maganin nau'in ciwon sukari na 2. (T2DM).
Marufi & Bayarwa
